Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | CES1 | P23141 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HPGDS | O60760 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL41617 | 1.00 | DAO (0.43) | DAOKIF11CYP2C19CYP1A2CES2 | |
| SCHEMBL1421302 | 1.00 | DAO (0.43) | DAOKIF11CYP2C19CYP1A2CES2 | |
| SCHEMBL73588 | 0.83 | DAO (0.43) | DAOKIF11CYP2C19CES2CES1 | |
| SCHEMBL1492740 | 0.83 | DAO (0.43) | DAOKIF11CYP2C19CES2CES1 | |
| SCHEMBL7432298 | 0.83 | DAO (0.43) | DAOKIF11CYP2C19CES2CES1 | |
| Hydrochloric Acid SCHEMBL9402263 | 0.82 | DAO (0.42) | DAOKIF11CYP2C19CES2CES1 | |
| SCHEMBL28251139 | 0.82 | CES2 (0.39) | DAOKIF11CES2CES1TSHR | |
| Hydrochloric Acid SCHEMBL5198564 | 0.82 | HDAC1 (0.40) | DAOKIF11CES2CES1TSHR | |
| SCHEMBL1827117 | 0.82 | DAO (0.42) | DAOKIF11CYP2C19CYP1A2CES2 | |
| SCHEMBL5788804 | 0.81 | CYP2C19 (0.43) | DAOKIF11CYP2C19CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025106527-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FRIEDREICH'S ATAXIA | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2025-05-22 | — | — | WO | disclosed |
| US-11866460-B2 | Broad-spectrum anti-infective peptides | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2024-01-09 | — | — | US | disclosed |
| EP-3313862-B9 | BROAD-SPECTRUM ANTI-INFECTIVE PEPTIDES | UNIV NANYANG TECH (SG) | 2023-10-04 | — | — | EP | disclosed |
| EP-3313862-B1 | BROAD-SPECTRUM ANTI-INFECTIVE PEPTIDES | UNIV NANYANG TECH (SG) | 2023-06-07 | — | — | EP | disclosed |
| US-20220402972-A1 | BROAD-SPECTRUM ANTI-INFECTIVE PEPTIDES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-12-22 | — | — | US | disclosed |
| WO-2022220749-A1 | ANTI-VIRAL PEPTIDE COMPOSITIONS AND METHODS TO IMPROVE BIOLOGICAL ACTIVITY THEREOF | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-10-20 | — | — | WO | disclosed |
| US-20220054590-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE THEREOF | JANSSEN BIOTECH, INC. | 2022-02-24 | — | — | US | disclosed |
| US-11083776-B2 | Protoxin-II variants and methods of use | JANSSEN BIOTECH, INC. (US) | 2021-08-10 | — | — | US | disclosed |
| EP-3277304-B1 | PROTOXIN-II VARIANTS AND METHODS OF USE | JANSSEN BIOTECH INC (US) | 2021-08-04 | — | — | EP | disclosed |
| US-20200087349-A1 | BROAD-SPECTRUM ANTI-INFECTIVE PEPTIDES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2020-03-19 | — | — | US | disclosed |
| US-20040014147-A1 | Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase | MIDCAP FINANCIAL TRUST | 2004-01-22 | — | — | US | disclosed |
| WO-2003070769-A2 | ORGANIC COMPOUNDS HAVING ANTI-ANGIOGENIC ACTIVITY | NOVARTIS AG (CH) | 2003-08-28 | — | — | WO | disclosed |
| WO-2003000915-A1 | METHOD FOR PRODUCING L-AMINO ACIDS | SHOWA DENKO K.K. (JP) | 2003-01-03 | — | — | WO | disclosed |
| US-6455523-B1 | ADMINISTERING 1,4-BENZODIAZEPINE DERIVATIVE AS ANTITUMOR OR ANTICARCINOGENIC AGENT | BRISTOL-MYERS SQUIBB COMPANY | 2002-09-24 | — | — | US | disclosed |
| US-6124121-A | Method for producing L-leucine | AJINOMOTO CO., INC. (JP) | 2000-09-26 | — | — | US | disclosed |
| US-6011029-A | BENZODIAZEPINE COMPOUNDS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-01-04 | — | — | US | disclosed |
| EP-0913466-A2 | Method for producing L-leucine | Ajinomoto Co., Ltd. (JP) | 1999-05-06 | — | — | EP | disclosed |
| EP-0892797-A1 | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-01-27 | — | — | EP | disclosed |
| WO-1997030992-A1 | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-08-28 | — | — | WO | disclosed |
| US-4110342-A | PENICILLIN AND CEPHALOSPORIN INTERMEDIATES | PFIZER INC. (US) | 1978-08-29 | — | — | US | disclosed |